Craft

Advanced
  • Home
  •  / Flightpath Biosciences
Flightpath Biosciences

Flightpath Biosciences

Flightpath Biosciences Summary

Company Summary

Overview
Flightpath Biosciences is a biotechnology company developing therapeutics for the treatment of tick-borne diseases. It offers proprietary oral drugs for the treatment of acute and Post Treatment Lyme Disease (PTLD).
Type
Private
Status
Active
Founded
2019
HQ
Berkeley, CA, US | view all locations
Website
https://flightpath.bio/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Matthew Tindall

    Matthew Tindall, Co-Founder, President and Chief Executive Officer

    • Curtis Scribner

      Curtis Scribner, Co-Founder, Chief Medical Officer and Head of Clinical and Regulatory

      • Mark de Souza

        Mark de Souza, Co-Founder and Executive Chairman

        • James Kanter

          James Kanter, VP, Operations and Manufacturing

          LocationsView all

          1 location detected

          • Berkeley, CA HQ

            United States

            2600 Tenth St #435

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX